title: Have the triptans fulfilled their promise?
authors.affiliation: Institute of Neurological Sciences, The Prince Henry and Prince of Wales Hospitals and The University of New South Wales, High Street, Randwick, NSW, 2031, Australia. a.zagami@unsw.edu.au
authors.forename: A S
authors.initials: AS
authors.lastname: Zagami
mesh_terms: D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D014363:Tryptamines
chemical_list: D007211:Indoles; D023303:Oxazolidinones; D010880:Piperidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan; D018170:Sumatriptan; C106783:naratriptan